Literature DB >> 12785000

Seprase complexes in cellular invasiveness.

Wen-Tien Chen1, Thomas Kelly.   

Abstract

A group of type II integral serine proteases, including dipeptidyl peptidase IV (DPP4/CD26), seprase/fibroblast activation protein alpha (FAPalpha) and related type II transmembrane prolyl serine peptidases, exert their mechanisms of action on the cell surface. DPP4 and seprase exhibit multiple functions due to their abilities to form complexes with each other and to interact with other membrane-associated molecules. Localization of the protease complexes at cell surface protrusions, called invadopodia, may have a prominent role in processing soluble factors (including chemokines and neuropeptide Y) and in degrading locally extracellular matrix components, that are essential to the cell migration and matrix invasion occurring during tumor invasion, angiogenesis and metastasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12785000     DOI: 10.1023/a:1023055600919

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  28 in total

1.  Expression levels of seprase/FAPα and DPPIV/CD26 in epithelial ovarian carcinoma.

Authors:  Mengzhen Zhang; Liwei Xu; Xiaoling Wang; Beibei Sun; Juan Ding
Journal:  Oncol Lett       Date:  2015-04-27       Impact factor: 2.967

2.  Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy.

Authors:  Susumu Saigusa; Yuji Toiyama; Koji Tanaka; Yasuhiro Inoue; Koichiro Mori; Shozo Ide; Hiroki Imaoka; Mikio Kawamura; Yasuhiko Mohri; Masato Kusunoki
Journal:  Int J Clin Oncol       Date:  2015-09-14       Impact factor: 3.402

3.  Gene expression changes in human lung cells exposed to arsenic, chromium, nickel or vanadium indicate the first steps in cancer.

Authors:  Hailey A Clancy; Hong Sun; Lisa Passantino; Thomas Kluz; Alexandra Muñoz; Jiri Zavadil; Max Costa
Journal:  Metallomics       Date:  2012-06-19       Impact factor: 4.526

4.  Whole Exome Sequencing Reveals a Novel Damaging Mutation in Human Fibroblast Activation Protein in a Family with Esophageal Squamous Cell Carcinoma.

Authors:  Fatemeh Fardi Golyan; Morteza Moghaddassian; Mohammad Mahdi Forghanifard; Samaneh Talebi; Moein Farshchian; Reihaneh Alsadat Mahmoudian; Mohammad Reza Abbaszadegan
Journal:  J Gastrointest Cancer       Date:  2020-03

5.  Potential of soluble CD26 as a serum marker for colorectal cancer detection.

Authors:  Oscar J Cordero; Monica Imbernon; Loretta De Chiara; Vicenta S Martinez-Zorzano; Daniel Ayude; Maria Paez de la Cadena; F Javier Rodriguez-Berrocal
Journal:  World J Clin Oncol       Date:  2011-06-10

6.  Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs).

Authors:  Michael L Pearl; Huan Dong; Shaun Tulley; Qiang Zhao; Marc Golightly; Stanley Zucker; Wen-Tien Chen
Journal:  Gynecol Oncol       Date:  2015-03-11       Impact factor: 5.482

Review 7.  The role of palladin in actin organization and cell motility.

Authors:  Silvia M Goicoechea; Daniel Arneman; Carol A Otey
Journal:  Eur J Cell Biol       Date:  2008-03-14       Impact factor: 4.492

8.  Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis.

Authors:  Younghee Lee; Xinan Yang; Yong Huang; Hanli Fan; Qingbei Zhang; Youngfei Wu; Jianrong Li; Rifat Hasina; Chao Cheng; Mark W Lingen; Mark B Gerstein; Ralph R Weichselbaum; H Rosie Xing; Yves A Lussier
Journal:  PLoS Comput Biol       Date:  2010-04-01       Impact factor: 4.475

9.  Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas.

Authors:  Loretta De Chiara; Ana M Rodríguez-Piñeiro; Francisco J Rodríguez-Berrocal; Oscar J Cordero; David Martínez-Ares; María Páez de la Cadena
Journal:  BMC Cancer       Date:  2010-06-28       Impact factor: 4.430

10.  Tumor-targeting efficacy of a BF211 prodrug through hydrolysis by fibroblast activation protein-α.

Authors:  Xiao-Ping Chai; Guang-Long Sun; Yan-Fen Fang; Li-Hong Hu; Xuan Liu; Xiong-Wen Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-11-09       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.